InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2024-02-02 00:00:00 ET · period of report 2024-02-01 · accession 0001477449-24-000011 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-02 2024-02-02 TDOC Kornwasser Laizer Pres, ENTERPRISE GROWTH S - Sale+OE $19.18 -7,882 57.2K -12% -$151.2K
D 2024-02-02 2024-02-01 TDOC Kornwasser Laizer Pres, ENTERPRISE GROWTH M - OptEx — +20.2K 65.1K +45% —
D 2024-02-02 2024-02-01 TDOC Kornwasser Laizer Pres, ENTERPRISE GROWTH M - OptEx $0.00 -20.2K 141.4K -12% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-02 S D 7,882 $19.18 57,223 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
2 Common Common Stock 2024-02-01 M A 20,198 — 65,105 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Derivative Restricted Stock Units 2024-02-01 M D 20,198 $0.00 141,390 D — · — to — 20,198 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.